Human proteins, including enzymes, manufactured with recombinant-DNA y
easts can be used to treat a variety of medical conditions; some redes
ign of molecular structure (and production techniques) should increase
their specificity, efficacy and immunotolerance. Prevention and treat
ment of diseases due to reactive oxygen species (ROS) and reactive nit
rogen species (RNS) may become possible, Therapeutic vaccines for some
diseases may be produced by design-specification for particular desir
able protein features, on an individual patient basis.